✨
AI Summary
- Trump increases pressure on MFN pricing; pharma engages on direct sales.
- Sanofi considers direct sales; Aurigene CEO on valuations.
- Novartis advances pipeline-in-a-product assets.
Guests on This Episode
AC
Aurigene Oncology CEO
1 podcast appearance